Literature DB >> 26290084

Time to Surgery Is Associated with Thirty-Day and Ninety-Day Mortality After Proximal Femoral Fracture: A Retrospective Observational Study on Prospectively Collected Data from the Danish Fracture Database Collaborators.

Anne Marie Nyholm1, Kirill Gromov1, Henrik Palm1, Michael Brix2, Thomas Kallemose1, Anders Troelsen1.   

Abstract

BACKGROUND: We hypothesized that undergoing surgery as soon as possible reduces early mortality in patients with a proximal femoral fracture. Our aim was to evaluate the association between surgical delay and early mortality in these patients.
METHODS: We performed a retrospective analysis of prospectively collected data from the Danish Fracture Database and the Civil Registration System on patients who were fifty years of age or older and had undergone surgery for a proximal femoral fracture. Femoral head fracture (classified as OTA/AO 31C per the OTA/AO classification system), high-energy trauma, pathological fractures, multiple fractures, and surgeries performed with implants not commonly used were excluded. End points were adjusted odds ratios for thirty-day and ninety-day mortality.
RESULTS: For the 3517 surgeries included in this study, the median patient age was 82.0 years (range, fifty-one to 107 years), 2458 patients (70%) were female, and 1720 surgeries (49%) were performed because of a trochanteric fracture. Within twelve hours, 722 of the surgeries (21%) had been performed; within twenty-four hours, 2482 surgeries (71%); within thirty-six hours, 3024 surgeries (86%); within forty-eight hours, 3242 surgeries (92%); and within seventy-two hours, 3353 surgeries (95%). Unsupervised surgeons with an education level below that of an attending surgeon performed the surgery in 1807 (51%) of all cases. The thirty-day mortality was 380 (10.8%) and the ninety-day mortality was 612 (17.4%). The risk of thirty-day mortality increased with a surgical delay of more than twelve hours (odds ratio, 1.45; p = 0.02), more than twenty-four hours (odds ratio, 1.34; p = 0.02), and more than forty-eight hours (odds ratio, 1.56; p = 0.02); the risk of ninety-day mortality increased with a surgical delay of more than twenty-four hours (odds ratio, 1.23; p = 0.04). An education level of the surgeon below that of an attending surgeon increased the risk of thirty-day mortality (odds ratio, 1.28; p = 0.035) and ninety-day mortality (odds ratio, 1.26; p = 0.016). Increasing American Society of Anesthesiologists score and male sex significantly increased both thirty-day and ninety-day mortality.
CONCLUSIONS: In this study, a surgical delay of more than twelve hours significantly increased the adjusted risk of thirty-day mortality and a surgical delay of more than twenty-four hours significantly increased the adjusted risk of ninety-day mortality. The adjusted risk of both thirty-day and ninety-day mortality increased significantly when the education level of the surgeon was below that of an attending surgeon. The study findings challenge orthopaedic departments to facilitate fast surgical treatment supported by attending orthopaedic surgeons.
Copyright © 2015 by The Journal of Bone and Joint Surgery, Incorporated.

Entities:  

Mesh:

Year:  2015        PMID: 26290084     DOI: 10.2106/JBJS.O.00029

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  46 in total

Review 1.  [Treatment of patients with fragility fractures].

Authors:  B Bücking; C Neuerburg; M Knobe; U Liener
Journal:  Unfallchirurg       Date:  2019-10       Impact factor: 1.000

2.  Association Between Wait Time and 30-Day Mortality in Adults Undergoing Hip Fracture Surgery.

Authors:  Daniel Pincus; Bheeshma Ravi; David Wasserstein; Anjie Huang; J Michael Paterson; Avery B Nathens; Hans J Kreder; Richard J Jenkinson; Walter P Wodchis
Journal:  JAMA       Date:  2017-11-28       Impact factor: 56.272

3.  CORR Insights®: The Frank Stinchfield Award: Total Hip Arthroplasty for Femoral Neck Fracture Is Not a Typical DRG 470: A Propensity-matched Cohort Study.

Authors:  Barbara Bordini
Journal:  Clin Orthop Relat Res       Date:  2016-06-21       Impact factor: 4.176

4.  Reducing mortality and morbidity following hip fracture: Is expedited surgery the way to go?

Authors:  Rajiv Gandhi; Anthony V Perruccio
Journal:  CMAJ       Date:  2016-06-13       Impact factor: 8.262

5.  Hip fracture time-to-surgery and mortality revisited: mitigating comorbidity confounding by effect of holidays on surgical timing.

Authors:  Siu Him Janus Wong; Xinshuo Christian Fang; King Hang Dennis Yee; Tak Man Wong; Cheuk Ting Terence Pun; Tak Wing Lau; Ka Li Frankie Leung
Journal:  Int Orthop       Date:  2018-01-03       Impact factor: 3.075

6.  Socioeconomic inequality in clinical outcome among hip fracture patients: a nationwide cohort study.

Authors:  P K Kristensen; T M Thillemann; A B Pedersen; K Søballe; S P Johnsen
Journal:  Osteoporos Int       Date:  2016-12-01       Impact factor: 4.507

7.  The implementation of a clinical pathway enhancing early surgery for geriatric hip fractures: how to maintain a success story?

Authors:  An Sermon; Ine Rochus; Bart Smeets; Willem-Jan Metsemakers; Dominique Misselyn; Stefaan Nijs; Harm Hoekstra
Journal:  Eur J Trauma Emerg Surg       Date:  2018-10-16       Impact factor: 3.693

8.  High mortality following distal femur fractures: a cohort study including three hundred and two distal femur fractures.

Authors:  Peter Larsen; Adriano Axel Ceccotti; Rasmus Elsoe
Journal:  Int Orthop       Date:  2019-05-12       Impact factor: 3.075

9.  Outcomes of Hemiarthroplasty and Total Hip Arthroplasty for Femoral Neck Fracture: A Medicare Cohort Study.

Authors:  Zhong Wang; Timothy Bhattacharyya
Journal:  J Orthop Trauma       Date:  2017-05       Impact factor: 2.512

10.  The patellar pubic percussion test: a simple bedside tool for suspected occult hip fractures.

Authors:  Stef Jozef Marie Smeets; Wouter Vening; Michiel Bernard Winkes; Gerrit Paulus Kuijt; Gerrit Dirk Slooter; Percival Victor van Eerten
Journal:  Int Orthop       Date:  2018-07-17       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.